Literature DB >> 19925829

Development and evaluation of a whole virus-based enzyme-linked immunosorbent assay for the detection of human metapneumovirus antibodies in human sera.

Michiko Okamoto1, Kanetsu Sugawara, Emi Takashita, Yasushi Muraki, Seiji Hongo, Katsumi Mizuta, Tsutomu Itagaki, Hidekazu Nishimura, Yoko Matsuzaki.   

Abstract

To apply serological testing for human metapneumovirus (hMPV) to large-scale sera samples, an enzyme-linked immunosorbent assay (ELISA) was developed in which purified virions were used as the antigen. The ELISA was evaluated using 102 human sera specimens from patients aged 0-59 years. There was a positive association between the ELISA results and neutralization test titers, with the correlation coefficients being greater in children <6 years old (rho=0.899, P<0.0001), which is consistent with a primary infection, than in persons >or=6 years old (rho=0.523, P<0.0001). Fifty sera samples were subjected to radioimmunoprecipitation to measure the quantity of antibodies to the fusion protein (RIP-F) and the nucleoprotein (RIP-N). The results showed significant associations between the ELISA titers and the amount of RIP-F as determined by radioimmunoprecipitation in children <6 years old (rho=0.804, P=0.0083) and in persons >or=6 years old (rho=0.577, P=0.0009). The correlation between the ELISA titer and the amount of RIP-N determined by radioimmunoprecipitation was not significant in persons >or=6 years old (rho=0.417, P=0.0829), although this correlation was significant in children <6 years old (rho=0.764, P=0.0137). The ELISA titer correlated with the amount of antibodies to the F protein, but not to the N protein. This whole virus-based ELISA will be useful for the diagnosis of hMPV infection in clinical laboratories and is also useful for the large-scale investigations, such as seroprevalence among residents of a particular region. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925829     DOI: 10.1016/j.jviromet.2009.11.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

Review 1.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China.

Authors:  Guilan Lu; Richard Gonzalez; Li Guo; Chao Wu; Jiang Wu; Guy Vernet; Gláucia Paranhos-Baccalà; Jianwei Wang; Tao Hung
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

3.  Clinical Features of Human Metapneumovirus Pneumonia in Non-Immunocompromised Patients: An Investigation of Three Long-Term Care Facility Outbreaks.

Authors:  Yosuke Karimata; Takeshi Kinjo; Gretchen Parrott; Ayako Uehara; Daijiro Nabeya; Shusaku Haranaga; Futoshi Higa; Masao Tateyama; Keiko Miyagawa; Tomoo Kishaba; Kanako Otani; Michiko Okamoto; Hidekazu Nishimura; Jiro Fujita
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

Review 4.  Metapneumovirus Infections and Respiratory Complications.

Authors:  Susanna Esposito; Maria Vincenza Mastrolia
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

5.  Epidemiological study of zoonoses derived from humans in captive chimpanzees.

Authors:  Takanori Kooriyama; Michiko Okamoto; Tomoyuki Yoshida; Toshisada Nishida; Toshio Tsubota; Akatsuki Saito; Masaki Tomonaga; Tetsuro Matsuzawa; Hirofumi Akari; Hidekazu Nishimura; Takako Miyabe-Nishiwaki
Journal:  Primates       Date:  2012-08-14       Impact factor: 2.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.